December 12, 2013
Two more universities will give updates on their investigations into clinical trials they led on Diovan (valsartan), Novartis Pharma’s blood pressure drug rocked by a data manipulation scandal. Nagoya University, which conducted the NAGOYA Heart Study, will hold a news...read more